Pro Pharma Announces Medical Specialty Pharmacy Analytics for Quick Problem Resolution

CHATSWORTH, Calif. - Dec. 13, 2017 - PRLog -- Pro Pharma Pharmaceutical Consultants, Inc., a pharmaceutical consulting organization which focuses on data analytical expertise, is pleased to announce our newly revised Medical Specialty Pharmacy Analytics (http://www.propharmaconsultants.com/cmr.html) .

According to Dr. Craig Stern, President, "These innovative analyses and reporting follow Claim Adjudication Rules and target Best Practices, which leads to significant Cost Savings.   They are based on integrated datasets of medical, pharmacy, laboratory, genomics and enrollment to illustrate the complete picture of the medical benefit performance utilizing a dashboard approach; which is then allows all formats in a client-specific cloud-based approach for ease of use."

Specialty Data Analytics (http://prodataanalytics.net/csa.html) is not new to Pro Pharma: health plans, government entities and self-insured employers have long had a prime interest in integrated datasets, and most particularly medical analyses.

"Pro Pharma has been analyzing clinical therapeutics across medical and pharmacy benefits for many years", states Carol Stern, CEO.  Pro Pharma's latest specialty analytics leverages custom-built technology and data mining to identify actionable strategies to contain costs and improve the health of plan members.

According to Dr. Craig Stern, President of Pro Pharma Pharmaceutical Consultants, Inc., "This comprehensive approach allows benefits, financial and clinical managers the ability to "drill down" from a more global perspective at a very high level of analytical reporting, to a detailed view, and includes the following:"

    +Comparative Usage, Cost, and Utilization
    +Total Specialty Medication Spend Across All Locations of Service
    +Cost Accounting, Discounting & Pricing Comps for Every Penny Spent
    +Pre-& Post Authorization Evaluations, Testing and Validation of All Claims Against Approved Diagnoses, FDA Labeling, Days' Supply and Dosing Standards
    +Compliance Testing of Claims Validity and Completeness
    +Location of Service Optimization – Centers of Excellence and Best-In-Class Comparisons
    +Evaluation of Outcomes of Various Therapies – Adverse Drug Reaction, Drug-Induced Disease Risk Profiles, Compliance, Drug Holiday Evaluations, and Genomics Testing

Pro Pharma analyses are directed to optimizing management and oversight of specialty medications to meet state and federal regulatory requirements, via Cloud-Based Media.  From enterprise to patient-specific issues, Pro Pharma's analytics provide a "Toolkit" of all key tools which payers require to manage Medical Specialty Drug Spend demanding area of therapeutics.

Call and/or email now to schedule your Live Demo and One-on-One Free 15-Minute Consultation to begin developing your Organization's Call to Action.

About PRO PHARMA

PRO PHARMA is a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.

As a primary service to plan sponsors for achieving below trend results, PRO PHARMA provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.

PRO PHARMA's Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators.   PRO PHARMA markets Biotech Modeling™, Invoice Screening™, Quality Management Program™, and Treatment Calendar™. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.

For more information about PRO PHARMA, please visit http://www.propharmaconsultants.com.